恩华药业(002262.SZ)：盐酸硫必利片通过仿制药一致性评价

Core Viewpoint - Enhua Pharmaceutical has received approval from the National Medical Products Administration for the supplementary application of Sulfobutyl Ether Beta-Cyclodextrin Tablets, which has passed the consistency evaluation of quality and efficacy for generic drugs [1] Company Summary - Enhua Pharmaceutical's Sulfobutyl Ether Beta-Cyclodextrin Tablets are indicated for the treatment of chorea, Tourette syndrome, and senile psychosis, and can also be used for ethanol intoxication [1]